CV Sciences Inc (CVSI)
OTHER OTC:CVSI
Want to see CVSI full AI Analyst Report?
CVSI Stock Chart & Stats
$0.09
>-$0.01(-7.69%)
At close: 4:00 PM EST
$0.09
>-$0.01(-7.69%)
Day’s Range― - ―
52-Week Range$0.02 - $0.10
Previous CloseN/A
Volume110.38K
Average Volume (3M)246.65K
Market Cap
$5.80M
Enterprise Value$7.13M
Total Cash (Recent Filing)$278.00K
Total Debt (Recent Filing)$1.61M
Price to Earnings (P/E)―
Beta0.67
Next Earnings
May 08, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding193,458,420
10 Day Avg. Volume158,629
30 Day Avg. Volume246,649
Financial Highlights & Ratios
PEG Ratio0.19
Price to Book (P/B)7.71
Price to Sales (P/S)0.82
P/FCF Ratio-21.93
Enterprise Value/Market Cap1.23
Enterprise Value/Revenue0.52
Enterprise Value/Gross Profit1.06
Enterprise Value/Ebitda-12.70
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improved Profitability & MarginsMaterial margin expansion to 49% and a positive adjusted EBITDA quarter indicate the company has increased pricing, cost control, or mix benefits that improve sustainable profitability potential, reducing the runway needed for break-even and supporting reinvestment.
Product Innovation & DiversificationA high share of revenue from recent launches shows effective product development and faster SKU renewal, reducing dependence on legacy SKUs. New launches like Empowr expand the addressable wellness market beyond CBD, supporting more durable revenue streams.
Balance-Sheet Restructuring & FlexibilityThe amended notes eliminate monthly cash redemptions and add conversion mechanics, easing near-term liquidity demands and giving management runway to focus on operations and bolt-on M&A, materially improving structural financial flexibility.
Bears Say
Declining Revenue TrendA multi-year revenue decline driven by out-of-stock and regulatory headwinds undermines operating leverage. Persistent top-line contraction makes sustained profitability harder to achieve and increases sensitivity to execution and market-share recovery.
Weak Cash Generation & Low LiquidityReturn to cash burn and a very small year-end cash balance limit the company's ability to fund working capital, marketing, or capex internally. This heightens dependency on external financing and raises structural liquidity risk over the next several months.
Rising Leverage & Dilution RiskHigher debt-to-equity reduces financial resilience and combined with conversion features creates meaningful dilution risk if debt is satisfied with equity. This structural mix can weaken shareholder value and constrain strategic options long-term.
CV Sciences News
CVSI FAQ
What was CV Sciences Inc’s price range in the past 12 months?
CV Sciences Inc lowest stock price was $0.02 and its highest was $0.10 in the past 12 months.
What is CV Sciences Inc’s market cap?
CV Sciences Inc’s market cap is $5.80M.
When is CV Sciences Inc’s upcoming earnings report date?
CV Sciences Inc’s upcoming earnings report date is May 08, 2026 which is in 22 days.
How were CV Sciences Inc’s earnings last quarter?
CV Sciences Inc released its earnings results on Mar 26, 2026. The company reported -$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.001.
Is CV Sciences Inc overvalued?
According to Wall Street analysts CV Sciences Inc’s price is currently Overvalued.
Does CV Sciences Inc pay dividends?
CV Sciences Inc does not currently pay dividends.
What is CV Sciences Inc’s EPS estimate?
CV Sciences Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CV Sciences Inc have?
CV Sciences Inc has 193,458,420 shares outstanding.
What happened to CV Sciences Inc’s price movement after its last earnings report?
CV Sciences Inc reported an EPS of -$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of CV Sciences Inc?
Currently, no hedge funds are holding shares in CVSI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
CV Sciences Inc
CV Sciences, Inc. (CVSI) is a biotechnology company focused on the research, development, and commercialization of products derived from hemp extract, particularly those containing cannabidiol (CBD). Operating primarily in the wellness and pharmaceutical sectors, CV Sciences offers a range of products including dietary supplements, topical applications, and pharmaceutical formulations aimed at promoting health and well-being. The company is dedicated to providing high-quality, science-backed products that leverage the therapeutic potential of cannabinoids.
CVSI Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant improvements in gross margin, cash flow, and cost efficiency, alongside successful new product developments and strategic M&A integration. However, challenges such as revenue decline, regulatory issues, and a decrease in B2C revenue were noted. Despite these challenges, the company's positive adjusted EBITDA and improved financial metrics demonstrate progress towards profitability.View all CVSI earnings summariesTechnical Analysis
cbdMD
―
Cosmos Holdings
―
IM Cannabis Corp
―
―
Incannex Healthcare Limited Sponsored ADR
―
Ownership Overview
―
Insiders
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---